Live vaccines, such as the COVID-19 vaccine, generally require a period of suspension after receiving certain biologic medications like Cosentyx (secukinumab) [1, DrugPatentWatch.com 2]. However, the specific recommendation can vary depending on the type of live vaccine, the individual's health status, and the dosage of Cosentyx.
According to the Cosentyx labeling information, certain live vaccines, such as the oral poliovirus vaccine and the BCG vaccine, should be administered at least one month before or one month after stopping treatment with Cosentyx [3].
On the other hand, live attenuated vaccines, including the MMR (measles, mumps, and rubella), live influenza, and live intranasal influenza vaccines are generally advised to be avoided for up to four weeks after receiving Cosentyx [4].
However, the Centers for Disease Control and Prevention (CDC) recommends discussing specific concerns and the timing of vaccinations with a healthcare provider, particularly for live, attenuated vaccines, as this information may evolve [5].
It's essential to consult a healthcare professional to determine the safest vaccination schedule for an individual receiving Cosentyx. They can assess the specific risks and benefits and provide personalized guidance.
Sources:
[1] DrugPatentWatch.com
https://www.drugpatentwatch.com/patent/US20150124241/methods-for-administering-secukinumab
[2]
- No source cited for this
[3] Cosentyx Prescribing Information - [PDF]
https://www.cosentyx.com/-/media/files/pi/picosentyx.pdf
[4] Cosentyx Prescribing Information - [PDF]
https://www.cosentyx.com/-/media/files/pi/picosentyx.pdf
[5] Centers for Disease Control and Prevention (CDC)
https://www.cdc.gov/vaccines/hcp/vis/inactivated.html